Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization.
Pedro
P
Arriola-Villalobos
Juan
J
Donate-López
Cristina
C
Calvo-González
Juan
J
Reche-Frutos
Nicolás
N
Alejandre-Alba
David
D
Díaz-Valle
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003528:Carcinoma, Adenoid Cystic / Q000532:radiotherapy*; D006801:Humans; D007267:Injections; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000150:complications*; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab